The National Institute for Health and Care Excellence (NICE) faced "difficult decisions" when it deemed a breast cancer drug which can extend sufferers lives by "up to six months" was too expensive, according to a health expert.
Dr Hilary Jones told Daybreak the £90,000 price tag per patient would have meant taking funds away from other vital services the NHS provides.
More top news
Scientists believe they may have found the key to fighting HIV - and it rests in the immune system of llamas.
The United Nations has made a renewed and record-breaking global appeal, after falling well short of its last request for financial help.
It used to be the most important club on the northern variety circuit, but since Bernard Manning's death the club no longer draws the crowds